Browsing Wolfson Institute of Preventive Medicine by Author "Noyce, A"
Now showing items 1-20 of 46
-
Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study
Hone, L; Jacobs, B; Noyce, A; Dobson, R (2021) -
Age-specific effects of childhood body mass index on multiple sclerosis risk
Hone, L; Jacobs, BM; Marshall, C; Giovannoni, G; Noyce, A; Dobson, R (2022) -
Assessing the screening performance of three abbreviated smell tests in Parkinson's disease
Goodwin, G; Li, H; Ismail, A; Azevedo, H; Giovannoni, G; Schrag, A; Lees, A; Cuzick, J; Bestwick, J; Auger, S (2020-09)Meeting Abstract 1408 from Movement-Disorder-Society (MDS) International Virtual Congress, SEP 12-16, 2020 -
The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
Cheong, J L Y; de Pablo-Fernandez, E; Foltynie, T; Noyce, A (IOS Press, 2020-04-24)In recent years, an emerging body of evidence has forged links between Parkinson’s disease (PD) and type 2 diabetes mellitus (T2DM). In observational studies, those with T2DM appear to be at increased risk of developing ... -
Cryptococcal meningitis in apparently immunocompetent patients: association with idiopathic CD4+ lymphopenia.
Shribman, S; Noyce, A; Gnanapavan, S; Lambourne, J; Harrison, T; Schon, F (2018-04)We present two cases of cryptococcal meningitis in people subsequently diagnosed with idiopathic CD4+ lymphopenia. Both presented with new onset headaches without sinister features and were sent home on multiple occasions ... -
Domotics, smart homes and Parkinson’s disease
Noyce, A; Cristina Simonet, A (IOS Press, 2021-02-19) -
Effect Modification between Genes and Environment and Parkinson's Disease Risk
Perinan, MT; Brolin, K; Bandres-Ciga, S; Blauwendraat, C; Klein, C; Gan-Or, Z; Singleton, A; Gomez-Garre, P; Swanberg, M; Mir, P (2022) -
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.
Gonzalez-Robles, C; Bartlett, M; Burnell, M; Clarke, CS; Haar, S; Hu, MT; Huxford, B; Jha, A; Lawton, M; Noyce, A (2023-12-22)BACKGROUND: Clinical trials of disease-modifying therapies in PD require valid and responsive primary outcome measures that are relevant to patients. OBJECTIVES: The objective is to select a patient-centered primary outcome ... -
Gene-environment interactions in multiple sclerosis: a uk biobank study
Jacobs, B; Noyce, A; Bestwick, J; Belete, D; Giovannoni, G; Dobson, R (2020-12)Meeting abstract from 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), SEP 11-13, 2020 -
Gene-environment interactions in Multiple Sclerosis: a UK Biobank study
Dobson, R; Noyce, A; Giovannoni, G -
The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study
Foote, I; Jacobs, B; Mathlin, G; Watson, C; Bothongo, PLK; Waters, S; Dobson, R; Noyce, A; Bhui, K; Korszun, A (2021-03-02)Preprint -
GP2: training the next generation of Parkinson's disease genetics researchers - wherever they are in the world
Dey, S; Noyce, A; Bale, C; Kuhl, M; Leonard, H; Lewis, P; Stott, S; Adams, S; Martinez-Carrasco, A; Stecher, B (2021) -
HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes
Huxford, B; Haque, T; Joseph, A; Simonet, C; Gallagher, D; Budu, C; Dobson, R; Noyce, A (2021) -
Identification of prodromal Parkinson's Disease - we may be able to but should we?
Noyce, A (Lippincott, Williams & Wilkins, 17-05-2024)Parkinson disease (PD) remains a progressive and incurable disease. Research over the past decade provides strong evidence of a detectible phase before the clinical diagnosis, known as the prodromal phase of PD (pPD). ... -
Impact of multiple sclerosis risk alleles on the plasma proteome.
Bernard Healey, SA; Giovannoni, G; Noyce, A; Dobson, R; Jacobs, BM (2023-10-18) -
Improving estimation of Parkinson's disease risk - enhancing the PREDICT-PD algorithm
Bestwick, J; Auger, S; Grosset, D; Kanavou, S; Giovannoni, G; Lees, A; Cuzick, J; Simonet, C; Rees, R; Rack, D (2020-09)Meeting abstract 182 from Movement-Disorder-Society (MDS) International Virtual Congress, SEP 12-16, 2020 -
Increased BMI May Protect against Parkinson's Disease: Evidence From Mendelian Randomisation Study
Noyce, A; Kia, D; Hemani, G; Nicolas, A; Price, T; Fernandez, E; Haycock, P; Lewis, P; Foltynie, T; Smith, GD (2017-06) -
The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017
Dobson, R; Noyce, A; MARSHALL, C (IOS Press, 2021-03-23) -
Insight Social determinants of neurological disease: tackling inequalities
Dobson, R; Marshall, C; Noyce, A (2022) -
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
Bandres-Ciga, S; Saez-Atienzar, S; Kim, JJ; Makarious, MB; Faghri, F; Diez-Fairen, M; Iwaki, H; Leonard, H; Botia, J; Ryten, M (2020-09)